Patient Guide: A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 174 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04576156
Status: ACTIVE_NOT_RECRUITING
Condition: Myelofibrosis
Phase: PHASE3

Find a Study Location Near You

This study is available at 174 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • La Jolla, California
  • Los Angeles, California
  • New Haven, Connecticut
  • • And 171 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily